Paradigm Health Announces Collaboration with the FDA to Transform Regulatory Review of Clinical Trial Data
The initiative will be implemented in two trials, using Paradigm Health's integrated technology platform to accelerate FDA review WASHINGTON and COLUMBUS, Ohio, April 28, 2026 /PRNewswire/ -- Today, Paradigm Health announced the launch of a landmark research collaboration with the U.S....
View original →